source
- Philips earmarks $322 million for pending DOJ settlement on sleep-apnea device recallPhilips' Respironics division announced it has reached an agreement in principle with the U.S. Department of Justice to settle the investigation into its sleep‑apnea device recall. The recall, ini…
- Ultragenyx cuts 20% of workforce and abandons Wilson disease gene therapy after mixed Q3 resultsUltragenyx said it will cut about 20% of its workforce, marking a second round of layoffs this year. The reductions will affect roughly a fifth of the company's employees. At the same time, the fi…